Ideal Cardiovascular Health Is Inversely Associated With Incident Cancer: The Atherosclerosis Risk in Communities Study
In 2010, the American Heart Association (AHA) defined the concept of ideal cardiovascular health according to 7 health behaviors or factors, which include smoking, physical activity, obesity, dietary intake, total cholesterol, blood pressure and blood sugar. The idea of working to attain the ideal goals for these 7 health metrics is now being promoted through the use of the My Life Check online health assessment tool and the Life's Simple Seven health campaign from the AHA and American Stroke Association. Several earlier studies have demonstrated that adherence to ideal levels of the metrics is associated with lower cardiovascular disease incidence. In this study we used data from the Atherosclerosis Risk in Communities Study to demonstrate that adherence to ideal levels of the AHA cardiovascular health metrics was associated with significantly lower rates of incident cancer over 17-19 years of follow-up. Atherosclerosis Risk in Communities Study participants meeting goals for 6-7 ideal health metrics at baseline had 51% lower risk of incident cancer than those meeting goals for 0 ideal health metrics. This association remained significant even after smoking was removed from the ideal health score. We believe clinicians can use this information to further motivate patients to adhere to a healthy lifestyle and monitor their blood sugar, blood pressure, and blood cholesterol. We also hope these results will encourage the AHA in their efforts to partner with cancer and other chronic disease advocacy groups to promote primordial prevention. See p 1270.
Smoking, Surgery, and Venous Thromboembolism Risk in Women: United Kingdom Cohort Study
Evidence about the effect of smoking on the incidence of venous thromboembolism, generally and in the postoperative period, is limited and inconsistent. We linked questionnaire data on smoking in a large United Kingdom cohort study (the Million Women Study) with hospital admission and death records to study venous thromboembolism incidence in relation to smoking, both in the absence of surgery and in the 12 weeks after surgery. During 6 years of followup, 4630 women were admitted to a hospital for or died of venous thromboembolism. In the absence of surgery, the risk of venous thromboembolism in current smokers was 40% higher than in never-smokers, with the risk increasing the more cigarettes women smoked. Similar relationships were found for women with a pulmonary embolism and for women with venous thrombosis alone. Smokers were more likely than never-smokers to have surgery. In the 12 weeks after surgery, current smokers had significantly higher risks of venous thromboembolism than never-smokers. In conclusion, smoking is another factor to consider in the assessment of venous thromboembolism risk in patients undergoing surgery. See p 1276.
Genetic Determinant for Amino Acid Metabolites and Changes in Body Weight and Insulin Resistance in Response to Weight-Loss Diets: The Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) Trial
Gene-environment interaction analysis is becoming one of the most important studies to provide support for the notion of a personalized prevention or medicine. However, related evidence from clinical trials is scarce. Recently, high levels of circulating branched-chain amino acids and aromatic amino acids were found to predict the development of type 2 diabetes mellitus and to be associated with insulin resistance. Meanwhile, genome-wide association studies identified a variant rs1440581 near the PPM1K gene related to the ratio of circulating branched-chain amino acids and aromatic amino acids and found that this gene affected the risk of diabetes mellitus. In the present study, we genotyped rs1440581 in 734 overweight or obese patients to examine the effects of the PPM1K variant on changes in body weight and insulin resistance in the 2-year Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial, in particular, gene-diet interactions. Our data indicated that individuals carrying the C allele of amino acid metabolite-associated variant rs1440581 may benefit less in weight loss and improvement of insulin sensitivity than those without this allele when undertaking an energy-restricted high-fat diet. The findings from our study lend support to the modification of diet intervention on metabolic effects of amino acids and provide novel information on effective dietary intervention strategies based on genetic background in preventing or curing diseases related to obesity and insulin resistance. See p 1283.
Donor Brain Death Exacerbates Complement-Dependent Ischemia/Reperfusion Injury in Transplanted Hearts
The majority of organs used for transplantation are acquired from brain-dead donors, and evidence from clinical and experimental studies indicates that brain death is a significant contributing factor to ischemia/reperfusion injury and subsequent inferior graft function and is detrimental to the outcome of kidney, heart, lung, and liver transplantations. We investigated the role of complement in brain death-associated ischemia/reperfusion injury of transplanted hearts using our recently described murine model. We show that donor brain death enhances complement activation and exacerbates ischemia/reperfusion injury in transplanted cardiac grafts. We also show that treatment of recipient mice with a targeted complement inhibitor protects against cardiac graft damage and that posttransplantation ischemia/reperfusion injury in grafts from brain-dead donors is reduced to a level at or below that seen in grafts from living donors. Furthermore, we demonstrate a clinical correlation between complement activation and inflammation in hearts from brain-dead versus living donors, and previous clinical studies have shown that recipients of living donor grafts have a reduced risk of primary graft failure Volume 127 ◼ Number 12 ◼ March 26, 2013
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March 26, 2013 and acute rejection, as well as a delayed onset of chronic rejection. The data suggest that complement inhibition may be used to ameliorate brain death-exacerbated ischemia/reperfusion injury and that treating the recipient will mitigate potential complications of donor therapy. A complement inhibitor targeted to the transplanted organ, as used in the present study, may also be given at multiple time points after transplantation with minimal effect on complement-dependent host immune or homeostatic functions. See p 1290.
Clinical Impact of Persistent Left Bundle-Branch Block After Transcatheter Aortic Valve Implantation With CoreValve Revalving System
A new-onset left bundle-branch block (LBBB) after surgical aortic valve replacement is associated with a worse prognosis. Of note, a new LBBB is quite frequent in patients undergoing transcatheter aortic valve implantation by means of the CoreValve Revalving system. Whether this conduction disturbance could have an ominous impact is still unclear. In this large multicenter registry, we observed a new-onset LBBB in >40% of the patients after the procedure. This percentage decreased at discharge to 27%. Patients who had an LBBB at discharge also had the LBBB at 30 days. On the other hand, at 30-day follow-up, no new LBBBs were observed among patients without LBBB at discharge. A new-onset LBBB was not associated with higher all-cause mortality, cardiac mortality, or hospitalization for heart failure at 30 days and at 1 year. At 30 days, but not at 1 year, patients presenting with a new-onset LBBB had a significantly higher rate of pacemaker implantation. From a clinical perspective, we found no evidence of any correlation between the development of LBBB and an increased risk of major adverse events. Nevertheless, these data highlight the need for closer follow-up of patients who develop an LBBB after transcatheter aortic valve implantation by means of the CoreValve Revalving system, because they are prone to develop arrhythmias that require permanent pacing. See p 1300.
Hydrogen Peroxide Promotes Aging-Related Platelet Hyperactivation and Thrombosis
Aging is associated with an increased incidence of thrombotic events such as stroke, myocardial infarction, deep vein thrombosis, and pulmonary embolism. However, the mechanisms by which aging increases susceptibility to thrombosis remain elusive. One potential causal link between aging and thrombotic susceptibility may be oxidative stress, which increases with aging and is hypothesized to play a pivotal role in cardiovascular disease. The objective of this study was to use a mouse model to investigate the mechanistic role of oxidative stress in aging-related thrombosis. To do so, we tested the specific hypothesis that aged mice overexpressing an antioxidant enzyme, glutathione peroxidase-1, are protected from experimental thrombosis. Our data demonstrate that susceptibility to both arterial and venous thrombosis is enhanced with aging by a mechanism involving hydrogen peroxide and that peroxide-mediated hyperactivation of platelets in aged mice may be particularly important for this prothrombotic phenotype. These findings suggest that targeted approaches to prevent the accumulation of peroxide in activated platelets may represent an alternative to general antioxidant therapy as a therapeutic strategy to prevent thrombotic complications of aging. See p 1308.
Hemopexin Therapy Improves Cardiovascular Function by Preventing Heme-Induced Endothelial Toxicity in Mouse Models of Hemolytic Diseases
Two worldwide-distributed hemolytic anemias are sickle cell disease and β-thalassemia. Both disorders are characterized by inflammatory vasculopathy resulting from a complex scenario involving abnormal red cells, neutrophils, proinflammatory cytokines, and a highly pro-oxidant plasma environment. The destruction of abnormal red cells induced both intravascular and extravascular hemolysis. Intravascular hemolysis is characterized by the presence of an aliquot of plasma free hemoglobin that rapidly losses its heme group, binding the endogenous hemopexin (Hx). Thus, hemolytic anemias are characterized by relative Hx deficiency with the presence of circulating toxic free heme. This promotes membrane lipid peroxidation and severe cell oxidative stress with the production of reactive oxygen species that act directly on the endothelial wall and inactivate nitric oxide, impairing vascular function. Here, we show that treatment with exogenous Hx promotes heme recovery and prevents heme-iron loading in endothelial and heart cells, limiting the induction of heme oxygenase-1, adhesion molecules, reactive oxygen species production, and nitric oxide synthase/nitric oxide oxidative inactivation. In sickle cell disease mice, Hx reduced blood pressure and restored cardiac output, suggesting a key role for Hx in the protection against heme-induced cardiovascular dysfunction. We propose Hx as potent free-heme scavenger to be used as an additional therapeutic tool in the treatment of vasculopathy related to hemolytic disorders. See p 1317.
